Azienda Ospedaliero Universitaria Policlinico G. Rodolico-San Marco
Azienda Ospedaliero Universitaria Policlinico G. Rodolico-San Marco
Catania, Italy1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Assess the Efficacy and Safety of Weekly Doses of GLM101 in Participants With PMM2-CDG | Dyskinesias, Neurologic Manifestations, PMM2-congenital disorder of glycosylation, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, atactic disorder, non-human animal, nervous system disorder | Active, not recruiting | Phase 2 / Phase 3 | 2026-08-14 | NCT06892288 |